The FDA awards Fast Track designation to BW-20805 for hereditary angioedema, a therapy designed to reduce attacks through PKK ...

Previously, the Company had received CRLs in November 2023 and April 2025 due to insufficient evidence in addressing the ...

Vaccine effectiveness was 38 to 41 percent against influenza outpatient visits, 41 percent against flu-linked hospitalization ...

Overall, 5.7 percent of participants with MCI had one-year risk for any indication for anticoagulant and thrombolytic drugs ...

Only children who have specific conditions that suggest a focal evaluation or persistent faltering weight are recommended to undergo diagnostic testing.

A federal judge stays all votes by the restructured CDC vaccine panel, ruling that recent appointments likely violate the Federal Advisory Committee Act.

Dyslipidemia should be treated earlier to reduce lifelong risk for prolonged exposure to atherogenic lipoproteins ...

HealthDay News — Digital media use is consistently associated with risks to child and adolescent mental health and ...

Findings from the FIND-CKD trial indicate finerenone may provide a new treatment option for slowing renal function loss in ...

All-cause mortality significantly lower with GLP-1 RA use, with consistent benefit across major cancer types, most GLP-1 RA types.

Phase 3 ADorable-1 trial results show lebrikizumab-libkz provides skin clearance and itch relief in children with moderate to ...

HealthDay News — For children aged 2 to 5 years with atopic dermatitis (AD), roflumilast cream 0.05% has a favorable long-term safety profile and efficacy for up to 56 weeks, according to a study ...